Vanishing lung syndrome with community-acquired pneumonia and infection of bullae by Pekša, Andra et al.
CASE REPORT
451www.journals.viamedica.pl
Address for correspondence: Andra Pekša, Riga East University Hospital, Latvia; e-mail: andra.peksa@gmail.com 
DOI: 10.5603/ARM.a2021.0066  |  Received: 13.11.2020  |  Copyright © 2021 PTChP  |  ISSN 2451–4934  |  e-ISSN 2543–6031
This article is available in open access under Creative Common Attribution-Non-Commercial-No Derivatives 4.0 International (CC BY-NC-ND 4.0) license, allowing to download articles and share them with others as 
long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
Andra Pekša , Madara Tirzīte, Sergejs Daņilovs
Riga East University Hospital, Riga Stradins University, Latvia
Vanishing lung syndrome with community-acquired pneumonia 
and infection of bullae
Abstract 
We present a case of a 36-year old male who was a long-term smoker and was found to have giant bullous emphysema on 
chest imaging as an accidental finding. At the time, when his first chest CT was obtained, he was asymptomatic and was rec-
ommended to consult a pulmonologist but was lost to follow-up for a year until he presented to the emergency department with 
fever, dyspnea, and chest pain. He was admitted to a pulmonology department. Chest CT was performed and it revealed infected 
bullae containing air-fluid levels as a complication of community-acquired pneumonia. After successful antibacterial treatment, 
the patient was discharged and recommended to consult with a thoracic surgeon. A few months later, he had video-assisted 
thoracoscopic surgery and left upper lobectomy as part of definitive treatment.
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Introduction 
Giant bullous emphysema (GBE), also known 
as vanishing lung disease or type I bullous dis-
ease, is defined by giant bullae in one or both 
upper lobes occupying at least one-third of the 
hemithorax and compressing the normal sur-
rounding parenchyma [1]. It is a progressive 
disease in which the affected regions of the lung 
do not participate in gas exchange often leading 
to dyspnea, hypoxia, chest tightness, and spon-
taneous pneumothorax. Vanishing lung disease 
can often be asymptomatic, especially in younger 
patients, and manifests only when complica-
tions occur – most commonly infection of bullae 
or pneumothorax. The development of GBE is 
associated with smoking, inhaled drug abuse, 
alpha-1 antitrypsin deficiency, and connective 
tissue disorders.
Material and methods
A 36 year-old patient was admitted to the 
emergency department complaining of left-sided 
chest pain worsened by coughing and deep in-
spiration, cough with yellow-greenish discharge, 
non-foul smelling sputum, and dyspnea of a few 
days duration. Two days before hospitalization, 
he developed chills and fever up to 39°C. Upon 
admission, he had fever of 38.5°C, respiratory 
rate of 24×/min, and SpO2 at 93% on room air. 
Respiratory examination revealed crackles and 
wheezing on the left side. The examination of 
other systems was unremarkable. 
Laboratory examination revealed neutro-
philic leukocytosis (leukocytes 18.8 × 109/L) 
and increased CRP (211.3 mg/L). Other results 
were within reference ranges. Chest X-ray was 
performed and revealed consolidations on the 
left side with air-fluid levels and blunting of the 
left costophrenic angle (Figure 1). There was 
suspicion of possible empyema with free air in 
the pleural space.
For further investigations and treatment, 
the patient was admitted to the pulmonology 
department. Before initiating therapy with amoxi-
cillin/clavulanic acid, sputum and blood cultures 
were drawn. A chest CT scan was performed and 
revealed centrilobular and paraseptal emphysema 
predominantly in apical parts of the lungs and 
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a bulla in the left apex (~16 × 8.6 × 7.3 cm) with 
air-fluid levels. Another perihilar cavity with 
air-fluid levels was seen between the 6th and 8th 
segment together with smaller bullae in the 2nd 
and 9th segment. Free fluid in the left pleural space 
was noted up to 3.6 cm (Figure 2).
Even though the patient had purulent spu-
tum, the sputum culture came back unspecific re-
vealing only normal upper respiratory flora. Blood 
cultures were negative. Treatment with amoxicil-
lin/clavulanic acid was ineffective and patient 
still had a fever up to 39°C. Inflammatory markers 
were increasing which prompted a change in an-
tibacterial treatment to piperacillin/tazobactam. 
On this regiment, the patient’s overall condition 
rapidly improved and he became afebrile in 
4 days. One week later, his inflammatory mark-
ers markedly decreased (leukocytes — 15.29 × 
109/L, CRP — 17.4 mg/L). A follow-up CT scan 
2 weeks after initiation of piperacillin/tazobactam 
revealed improvement in pneumatization of the 
Figure 1. Chest X-ray PA revealing consolidations of the left lung with 
air-fluid levels and blunting of left costophrenic angle
Figure 2. Chest computed tomography in coronal and axillar plane revealing bulla on the left side with air fluid levels, adjacent consolidation of the 
lung, and pleural effusion
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left lung, but the bullae were still filled with fluid 
(Figure 3). The patient was referred to a thoracic 
surgeon and uniportal video-assisted thoraco-
scopy (VATS) with left upper lobectomy was 
indicated. The patient didn’t agree to any further 
treatment in the hospital and, against medical 
advice, was discharged with recommendations to 
consult a thoracic surgeon. Two months later, the 
patient was seen by a surgeon and was admitted 
to the thoracic surgery department for VATS. Af-
ter a successful postsurgical period, the patient 
was lost for further follow-up as was expected 
considering his low adherence to treatment and 
recommendations.
During the time of hospitalization and after 
additional questioning of the patient, it was de-
termined that he was a long-term smoker who had 
been smoking approximately 30 cigarettes a day 
since the age of 6 (45 pack years). As well, he 
unwillingly revealed to have often smoked mar-
ijuana as well. At the time of hospitalization, he 
had switched to electronic cigarettes, but was not 
able to quit smoking completely. He admitted that 
a year prior to his present hospitalization episode, 
he was hospitalized at another hospital with acute 
pancreatitis. There, a CT was performed that 
accidentally revealed giant bullous emphysema. 
The bullae had a “mass effect”, protruding and 
restricting left lung upper segments and moving 
the heart shadow to the right (Figure 4).
After marked improvement of the patient’s 
overall condition, full pulmonary function tests 
were performed which revealed air trapping 
(defined as an increase in RV and FRC) and de-
creased diffusing capacity — FEV1/FVC 80.30%, 
FEV1 82.5%, TLC 102.7%, RV 164%, FRC 175%, 
DLCO 65.7%. α1-antitrypsin plasma levels were 
within the normal range (1.8 g/L; reference values 
0.92–2.0 g/L).
Discussion 
Giant bullous emphysema (GBE), also re-
ferred to as vanishing lung syndrome, is a rare 
condition that typically presents in young male 
smokers or α1-antitrypsin deficient (AATD) pa-
tients. Bullae are formed by the destruction of 
interalveolar walls due to chronic or acute stretch 
injury with increased intraalveolar pressure [2]. 
On chest radiograph, a bulla has to take no less 
Figure 3. Chest computed tomography 2 weeks after initiation of antibacterial treatment with piperacillin/tazobactam. Air-fluid level in the bullae 
still present, but marked improvement in pneumatization of the lung is seen
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Figure 4. Chest CT performed one year prior, revealing giant bullous emphysema
than 30% of the hemithorax to be considered a gi-
ant bulla. Commonly, such patients present with 
progressive dyspnea due to the bulla compressing 
surrounding lung tissue and disturbing optimal 
gas exchange, but sometimes these patients can 
be asymptomatic and be unaware of the existing 
pathology [3].
The exact prevalence of vanishing lung syn-
drome remains unknown as only a small number 
of case reports and series have been reported. 
The specific cause of the pathology is obscure, 
but male predisposition and smoking (both cig-
arette and marijuana abuse) have been observed 
to be risk factors [4]. Similar to how only about 
30% of smokers develop emphysema (mostly 
panacinar), it is reasonable to assume that yet 
to be identified triggers and predisposing factors 
(acquired or inherited) lead to the development of 
GBE in the same population. On the other hand, 
the pathogenesis of bulla formation is similar 
and is due to an imbalance of proteases/anti-
proteases and oxidants/antioxidants in the lung. 
This disequilibrium causes a chain reaction at 
a cellular level leading to the eventual destruc-
tion of alveolar walls resulting in permanent and 
abnormal enlargement of distal airspaces [5]. 
Bullae developing in emphysema are air-filled, 
thin-walled cavities larger than 1cm in diameter 
leading to poor gas exchange due to reduced total 
alveolar surface area and fibrosis of the alveolar 
membrane [6].
In patients with established GBE, pulmonary 
function tests and α1-antitrypsin serum level 
measurements must be performed. In the report-
ed patient, AATD was initially highly suspected. 
However, as plasma levels were normal, no fur-
ther genetic studies were performed because it is 
not reimbursed by the government in our country. 
There is no precise data of α1-antitrypsin defi-
ciency prevalence in Latvia. The European data 
is scarce — it varies from 1 in 1,368 in Denmark 
to 1 in 58, 319 in Poland [7].
The natural history of vanishing lung syn-
drome is reported to be a progressive one, but 
the rate of it is highly variable [8]. Bullae can 
enlarge, compressing healthy lung parenchyma 
and interfering with normal respiratory mechan-
ics and gas exchange (increase in dead space 
fraction). Lung compliance decreases and work of 
breathing increases [5]. Usually, in patients with 
emphysema, we would expect to have a typical 
obstructive pattern in spirometry. However, as 
demonstrated by this patient, it is not always the 
case in GBE. This is also why the use of spirome-
try as a follow-up tool is questionable. Regarding 
follow-up, the most important issue is to monitor 
the patient closely for worsening of symptoms and 
for the development of possible complications.
In patients with GBE, important steps in 
treatment include smoking cessation and ad-
herence to vaccination schedules. It is assumed 
that in asymptomatic patients with GBE, a rea-
sonable first-line approach is the use of bron-
chodilators. However, as patients become more 
symptomatic or develop complications, especially 
pneumothorax, surgical intervention is required. 
The treatment of choice in GBE is bullectomy. 
Available data suggests that elective bullectomy 
has good results. In a 5-year follow-up study of 
41 patients with giant bullous emphysema who 
had undergone elective bullectomy, improve-
ments in symptoms and lung function (signifi-
cant improvements in lung volumes, FEV1, and 
the FEV1/ FVC ratio over baseline) were noted. 
As well, bullae did not reappear and residual 
bullae did not become enlarged at the site of the 
bullectomy. During follow-up, the dyspnea score 
was reduced significantly soon after bullectomy 
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and remained so even up to the fourth year of 
follow-up. The bullectomy approach is associated 
with a decreased risk of infection and pneumotho-
rax [9]. As of now, there is no consensus available 
on the ideal timing for surgery or even follow-up 
of GBE patients.
The reported patient was asymptomatic 
and was unaware of the existing pathology until 
hospitalization due to acute pancreatitis and ac-
cidental CT findings of bullous emphysema. At 
that moment, his pulmonary function tests were 
better than expected – the deviations seen in this 
patient’s case were increased RV and FRC (above 
120%) with normal TLC levels, as well as decrease 
in DLCO due to bullae leading to a decrease in 
surface area where gas exchange takes place. As 
a result, the consulting pulmonologist prescribed 
treatment with bronchodilators. However, the 
patient was not adherent to the treatment proto-
col as the bullous changes were not causing any 
symptoms and did not interfere with his daily 
activities. One year later, he presented with acute 
worsening of the symptoms and community-ac-
quired pneumonia with infection of the bullae 
which prompted a lengthy stay in the hospital and 
surgical intervention. This case shows that even 
though the disease is asymptomatic, follow-up 
is important as pathology can lead to serious 
complications such as infection or rupture of 
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